<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05089240</url>
  </required_header>
  <id_info>
    <org_study_id>ESS-TEC 191</org_study_id>
    <nct_id>NCT05089240</nct_id>
  </id_info>
  <brief_title>Objective and Subjective Evaluation of Ophthalmic Lenses With Extra Power</brief_title>
  <official_title>Data Collection of Objective Parameters and Subjective Feedback on Visually Fatigued Subjects and Evaluation of the Effect of Ophthalmic Lenses to Alleviate Visual Fatigue</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Essilor International</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Elite School of Optometry and Sankara Nethralaya</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Essilor International</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate subjective visual performance and objective visual parameters when wearing&#xD;
      ophthalmic lenses with extra power (+0.4 D or +0.6 D), and ophthalmic lenses with a selective&#xD;
      blue cut filter.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 6, 2016</start_date>
  <completion_date type="Actual">July 1, 2017</completion_date>
  <primary_completion_date type="Actual">December 2, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The difference in number of participants with treatment-related adverse events between the two lenses</measure>
    <time_frame>Immediately after the first and second wearing period (21 days each)</time_frame>
    <description>Any untoward medical occurrence, unintended disease or injury, or any untoward clinical signs (including an abnormal laboratory finding) in subjects, users or other persons whether or not related to the investigational medical device. Determined by subject's spontaneous reporting, the Investigator's non-leading questioning and his/her evaluation.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">127</enrollment>
  <condition>Asthenopia</condition>
  <arm_group>
    <arm_group_label>20-29 years (+0.40D extra power)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>30-35 years (+0.40D extra power)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>20-29 years (+0.40D extra power with blue cut)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ophthalmic lens with extra power</intervention_name>
    <arm_group_label>20-29 years (+0.40D extra power with blue cut)</arm_group_label>
    <arm_group_label>20-29 years (+0.40D extra power)</arm_group_label>
    <arm_group_label>30-35 years (+0.40D extra power)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjective report of visual fatigue&#xD;
&#xD;
          -  Non-presbyopes&#xD;
&#xD;
          -  Permanent wearers who wear glasses for at least 5 hours a day&#xD;
&#xD;
          -  Distance refractive error within the range of [+6.00 to -6.00]* (with cylinder in the&#xD;
             negative form),&#xD;
&#xD;
          -  Cylindrical component of the refractive error within the range of 0 to 2 D in both&#xD;
             eyes,&#xD;
&#xD;
          -  Anisometropia ≤ 1.00 D in sperical equivalent,&#xD;
&#xD;
          -  Visual acuity of +0.10 logMAR or better in each eye with new prescription at distance&#xD;
             (high contrast/high luminance),&#xD;
&#xD;
          -  Distance visual acuity difference ≤0.20 logMAR between right and left eye (high&#xD;
             contrast, high luminance)&#xD;
&#xD;
          -  Near binocular visual acuity of +0.10 logMAR or better with a new prescription (high&#xD;
             contrast, high luminance),&#xD;
&#xD;
          -  Study frame characteristics: Frame B size at least 22 mm&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Vulnerability of the subject,&#xD;
&#xD;
          -  Participation in another study which might have an influence on vision or interfere&#xD;
             with study assessments,&#xD;
&#xD;
          -  Binocular vision problems,&#xD;
&#xD;
          -  Known ocular pathology (e.g., age-related macular degeneration, glaucoma…),&#xD;
&#xD;
          -  Any previous ocular surgery which might have an influence on vision or interfere with&#xD;
             study assessments (e.g., iridectomy, refractive surgery…),&#xD;
&#xD;
          -  Any untreated and/or uncontrolled systemic condition which might have an influence on&#xD;
             vision, or interfere with study assessments (e.g., uncontrolled diabetes, uncontrolled&#xD;
             high blood pressure…),&#xD;
&#xD;
          -  Any medical treatment or medication that might have an influence on vision or&#xD;
             interfere with study assessments (e.g., antidepressants, drugs with atropinic&#xD;
             effects…),&#xD;
&#xD;
          -  Knowledge/expertise in optometry, ophthalmic lenses, or optics based on past or&#xD;
             current professional activity (e.g., optometrists, opticians, ophthalmologists…)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>39 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 28, 2021</study_first_submitted>
  <study_first_submitted_qc>October 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 22, 2021</study_first_posted>
  <last_update_submitted>October 10, 2021</last_update_submitted>
  <last_update_submitted_qc>October 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthenopia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

